1110 related articles for article (PubMed ID: 10980598)
21. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
[TBL] [Abstract][Full Text] [Related]
23. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
[TBL] [Abstract][Full Text] [Related]
24. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
[TBL] [Abstract][Full Text] [Related]
25. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
Wang XJ; Greenhalgh DA; Roop DR
Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
[TBL] [Abstract][Full Text] [Related]
26. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas.
Dominey AM; Wang XJ; King LE; Nanney LB; Gagne TA; Sellheyer K; Bundman DS; Longley MA; Rothnagel JA; Greenhalgh DA
Cell Growth Differ; 1993 Dec; 4(12):1071-82. PubMed ID: 8117621
[TBL] [Abstract][Full Text] [Related]
27. Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in explant culture following a single exposure to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
Molloy CJ; Laskin JD
Cancer Res; 1987 Sep; 47(17):4674-80. PubMed ID: 2441853
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of malignant conversion in skin carcinogenesis.
Yuspa SH; Greenhalgh DA
Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
[TBL] [Abstract][Full Text] [Related]
29. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
Masuelli L; Focaccetti C; Cereda V; Lista F; Vitolo D; Trono P; Gallo P; Amici A; Monaci P; Mattei M; Modesti M; Forni G; Kraus MH; Muraro R; Modesti A; Bei R
Int J Oncol; 2007 Feb; 30(2):381-92. PubMed ID: 17203220
[TBL] [Abstract][Full Text] [Related]
30. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
31. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
Piepkorn M; Predd H; Underwood R; Cook P
Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
[TBL] [Abstract][Full Text] [Related]
32. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
33. Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis.
Segrelles C; Lu J; Hammann B; Santos M; Moral M; Cascallana JL; Lara MF; Rho O; Carbajal S; Traag J; Beltrán L; Martínez-Cruz AB; García-Escudero R; Lorz C; Ruiz S; Bravo A; Paramio JM; DiGiovanni J
Cancer Res; 2007 Nov; 67(22):10879-88. PubMed ID: 18006833
[TBL] [Abstract][Full Text] [Related]
34. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
36. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
37. Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis.
Mulherkar R; Kirtane BM; Ramchandani A; Mansukhani NP; Kannan S; Naresh KN
Oncogene; 2003 Apr; 22(13):1936-44. PubMed ID: 12673199
[TBL] [Abstract][Full Text] [Related]
38. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice.
Bol DK; Kiguchi K; Gimenez-Conti I; Rupp T; DiGiovanni J
Oncogene; 1997 Apr; 14(14):1725-34. PubMed ID: 9135074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
